Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-25 @ 2:00 AM
NCT ID:
NCT00415194
Eligibility Criteria:
Inclusion Criteria:
* You must have head and neck cancer that has returned and cannot be treated with surgery or other types of treatment. OR You must have head and neck cancer that was just found and has spread to other parts of your body.
* You must have a performance status of 0,1 or 2. This means that you must at least be able to get around, be able to take care of yourself and must be up and about most of the day.
* Your test results must show that your liver, kidneys and blood cells are working normally.
* You must understand and sign the form that gives your agreement to willingly be part of the study.
* You must be at least 18 years of age.
Exclusion Criteria:
* You cannot have previously been given other treatment for cancer that has spread to other parts of your body.
* You cannot have a serious sickness that might keep you from finishing the study (for example a bad infection).
* You cannot have any extra fluid in your chest or bowel area unless your doctor tells you it can be drained before you join the study.
* You cannot have any cancer called nasopharyngeal cancer, paranasal sinus cancer, lip cancer, or salivary gland cancer.
* If you are taking high dose aspirin or other medicines called non-steroidal anti-inflammatory drugs and cannot stop taking them for at least 5 days, you cannot be in the study. Your doctor or a member of the study team can explain which drugs are non-steroidal anti-inflammatory drugs.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00415194
Study Brief:
Protocol Section:
NCT00415194